Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 8

1.

Potent mitogenicity of the RET/PTC3 oncogene correlates with its prevalence in tall-cell variant of papillary thyroid carcinoma.

Basolo F, Giannini R, Monaco C, Melillo RM, Carlomagno F, Pancrazi M, Salvatore G, Chiappetta G, Pacini F, Elisei R, Miccoli P, Pinchera A, Fusco A, Santoro M.

Am J Pathol. 2002 Jan;160(1):247-54.

2.

[Rearrangement of the RET gene in papillary thyroid carcinoma].

Wiench M, Włoch J, Oczko M, Gubała E, Jarzab B.

Wiad Lek. 2001;54 Suppl 1:64-71. Review. Polish.

PMID:
12182064
3.

RET/PTC rearrangement in thyroid tumors.

Nikiforov YE.

Endocr Pathol. 2002 Spring;13(1):3-16. Review.

PMID:
12114746
4.

[Oncogenes RET/PTC and mechanisms of their involvement in thyroid cancerogenesis].

Voskoboĭnyk LH.

Ukr Biokhim Zh (1999). 2009 Nov-Dec;81(6):17-25. Review. Ukrainian.

PMID:
20387655
5.

Mechanisms of mutagenesis in mammalian cells. Application to human thyroid tumours.

Sarasin A, Bounacer A, Lepage F, Schlumberger M, Suarez HG.

C R Acad Sci III. 1999 Feb-Mar;322(2-3):143-9. Review.

PMID:
10196666
6.

20 years of RET/PTC in thyroid cancer: clinico-pathological correlations.

Fusco A, Santoro M.

Arq Bras Endocrinol Metabol. 2007 Jul;51(5):731-5. Review.

7.

Papillary thyroid carcinoma tall cell variant.

Ghossein R, Livolsi VA.

Thyroid. 2008 Nov;18(11):1179-81. doi: 10.1089/thy.2008.0164. Review.

PMID:
18925842
8.

Molecular basis of thyroid cancer.

Farid NR, Shi Y, Zou M.

Endocr Rev. 1994 Apr;15(2):202-32. Review. No abstract available.

PMID:
8026388
Items per page

Supplemental Content

Write to the Help Desk